Laurus Labs Share Price Hits Fresh 52-Week High at Rs 1,993: Key Reasons Behind the Rally

Published: 21 September 2026 at 9:48 AM IST

Laurus Labs Share Price is in focus after the stock touched a fresh 52-week high of Rs 1,992.95 and closed at Rs 1,987.30, up Rs 32.05 or 1.64% from the previous close of Rs 1,955.25. The move came as the company’s market capitalisation stood at Rs 1,05,644.55 crore, placing the update firmly among the most watched Laurus Labs Share Price Today stories in the Indian Stock Market. The supplied data confirms the price event, but it does not establish a company-specific catalyst. That makes this Laurus Labs Stock News item useful for readers tracking Laurus Labs Share Price Live, Laurus Labs Latest News and Laurus Labs Share Price Update on Univest.

The session range was tight around the high: the stock opened at Rs 1,964.50, printed a low of Rs 1,964.50 and reached Rs 1,992.95, which was also the day’s high. Turnover stood at Rs 4.15 crore. In plain terms, the fresh yearly high is the central event, while the day’s numbers show how closely the market kept the stock around that peak. For readers searching Laurus Labs Share Price, Laurus Labs Share Price Today or Laurus Labs Stock Analysis, the verified figures show a clear one-year high event without adding any unverified explanation.

Laurus Labs Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,987.3
Previous Close	Rs 1,955.25
Today's Move	+Rs 32.05 (+1.64%)
Open	Rs 1,964.5
High	Rs 1,992.95
Low	Rs 1,964.5
Turnover	Rs 4.15 crore
Market Capitalisation	Rs 1,05,644.55 crore

Laurus Labs Ltd. (LAURUSLABS) traded at Rs 1,987.3 versus the previous close of Rs 1,955.25, a rise of 1.64%. The stock opened at Rs 1,964.5, reached a high of Rs 1,992.95 and touched a low of Rs 1,964.5.

Laurus Labs Share Price Today reflects a session in which the stock traded from Rs 1,964.50 to Rs 1,992.95 before settling at Rs 1,987.30. The day change of Rs 32.05 came after a previous close of Rs 1,955.25, and the fresh 52-week high matched the day’s peak. That means the stock not only moved higher on the day, but also established a new yearly high in the same session. Turnover of Rs 4.15 crore adds a factual measure of the day’s traded value without implying anything beyond the recorded transaction data.

For Laurus Labs Share Price News readers, the most important point is that the current price sat just below the session high at the close. That keeps the day’s price action relevant for anyone tracking Laurus Labs Share Price, Laurus Labs Share News and Laurus Labs News Today on NSE and BSE. The data shows a fresh 52 Week High event and a close near the top of the range; it does not, by itself, identify a cause. Univest tracks these event-led moves so readers can see the exact market data in context.

Laurus Labs Ltd. (LAURUSLABS) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 1,05,644.55 crore
P/E Ratio	96.62x
P/B Ratio	18.73x
ROE	18.31%
ROCE	18.2%
EPS	Rs 20.24
Book Value Per Share	Rs 104.37
Dividend Yield	0.1%

Laurus Labs Ltd. (LAURUSLABS) fundamental metrics show P/E 96.62x, P/B 18.73x, ROE 18.31%, ROCE 18.2%. These figures provide context only and are not a buy or sell signal.

Laurus Labs Ltd. has a market capitalisation of Rs 105644.55 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 96.62x, P/B at 18.73x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.31% and ROCE of 18.2%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 20.24, book value per share of Rs 104.37, dividend yield of 0.1%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.18x, median ROE of 11.69%, median ROCE of 13.32%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	96.62x
Benchmark Median P/E	32.18x
Benchmark Average P/E	48.49x
Benchmark P/E Range	3.4x to 683.5x
Company P/B Ratio	18.73x
Benchmark Median P/B	3.04x
Company ROE	18.31%
Benchmark Median ROE	11.69%
Company ROCE	18.2%
Benchmark Median ROCE	13.32%
Company Market Capitalisation	Rs 1,05,644.55 crore
Benchmark Median Market Cap	Rs 677.56 crore

Laurus Labs Ltd. (LAURUSLABS) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Laurus Labs Ltd. (LAURUSLABS) has a P/E ratio of 96.62x, which is above the benchmark median of 32.18x, a difference of +200.25%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Laurus Labs Ltd. (LAURUSLABS) has a ROE of 18.31%, which is above the benchmark median of 11.69%, a difference of +56.63%. Laurus Labs Ltd. (LAURUSLABS) has a ROCE of 18.2%, which is above the benchmark median of 13.32%, a difference of +36.64%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Cipla Ltd.	CIPLA	1,10,793.75	32.87	3.15	11.83	16
Aurobindo Pharma Ltd.	AUROPHARMA	99,828.06	26.89	2.56	9.93	12.76
Lupin Ltd.	LUPIN	98,069.81	17.74	4.12	27.11	28.86
Dr. Reddy's Laboratories Ltd.	DRREDDY	97,749.41	30.34	2.56	11.69	13.75
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,15,012.19	25.48	4.27	19.69	21.39

Laurus Labs Ltd. (LAURUSLABS) has a P/E ratio of 96.62x compared with the displayed peer median of 26.89x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.31% compares with a peer median of 11.83% across the companies shown in the table. ROCE stood at 18.2% versus the displayed peer median of 16%, providing a capital-efficiency comparison. Laurus Labs Ltd. (LAURUSLABS) has a market capitalisation of Rs 1,05,644.55 crore. Among the 5 peers shown, 2 have a larger market capitalisation.

Why Investors Are Watching Laurus Labs

• Laurus Labs Share Price touched a fresh 52-week high of Rs 1,992.95 and closed at Rs 1,987.30.
• The day change was Rs 32.05, or 1.64%, from the previous close of Rs 1,955.25.
• Market capitalisation stood at Rs 1,05,644.55 crore at the time of this update.
• P/E of 96.62 and P/B of 18.73 place Laurus Labs above the industry median benchmark in the supplied data.
• ROE of 18.31% and ROCE of 18.2% both sit above the same-industry medians in the benchmark snapshot.

About Laurus Labs

Laurus Labs Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied data identifies the company as Laurus Labs Ltd. (LAURUSLABS) and places it in a same-industry benchmark set used for this article. For readers following Laurus Labs Company News on Univest, the company profile is kept strictly to the verified sector and industry classification, along with the market data and financial metrics supplied in the workflow.

That factual framing helps keep Laurus Labs Share Price connected to the business context that is available in the dataset. Univest publishes this kind of Laurus Labs Share Price Today coverage so readers can connect the fresh 52-week high with the company’s broader listed-company profile, market capitalisation, valuation and profitability data.

Track Laurus Labs Share Price on Univest

Use Laurus Labs Ltd. (LAURUSLABS) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

You can track Laurus Labs Share Price on Univest for live price updates, fundamental ratios, shareholding pattern, 52-week levels and market insights. Univest also brings together Laurus Labs Share Price Today, Laurus Labs Stock News and Laurus Labs Stock Analysis in one place for easier monitoring.

Frequently Asked Questions

What is Laurus Labs Share Price today?

Ans. Laurus Labs Share Price was Rs 1,987.30 at the close of the reported session, up Rs 32.05 or 1.64% from the previous close of Rs 1,955.25. The stock also touched Rs 1,992.95 during the day.

Did Laurus Labs hit a fresh 52-week high?

Ans. Yes. Laurus Labs Share Price touched a fresh 52-week high of Rs 1,992.95 in the reported session. The closing price of Rs 1,987.30 remained close to that peak. The stock moved 1.64% during the session.

What was Laurus Labs market capitalisation?

Ans. Laurus Labs had a market capitalisation of Rs 1,05,644.55 crore in the supplied data. That places Laurus Labs Share Price in a large listed-company bracket within the Healthcare sector and Pharmaceuticals & Drugs industry.

How does Laurus Labs compare on valuation?

Ans. Laurus Labs Share Price carries a P/E of 96.62 and a P/B of 18.73. Both are above the same-industry median benchmark supplied in the data, which gives the stock a richer valuation context.

What do Laurus Labs profitability ratios show?

Ans. Laurus Labs reports ROE of 18.31% and ROCE of 18.2%. Both figures are above the industry median in the supplied benchmark, showing stronger returns than the typical company in the same industry set.

What are Laurus Labs EPS, book value and dividend yield?

Ans. Laurus Labs EPS is Rs 20.24, book value per share is Rs 104.37 and dividend yield is 0.1%. These figures help readers connect Laurus Labs Share Price with earnings, accounting value and payout data.

Which sector and industry does Laurus Labs belong to?

Ans. Laurus Labs belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. That makes Laurus Labs Share Price relevant to broader sector comparison, peer analysis and healthcare market updates.

How did Laurus Labs trade during the session?

Ans. Laurus Labs opened at Rs 1,964.50, touched a low of Rs 1,964.50 and a high of Rs 1,992.95, before closing at Rs 1,987.30. The session therefore ended close to the day’s peak.

Who are the selected peers for Laurus Labs?

Ans. The supplied peer set includes Cipla, Aurobindo Pharma, Lupin, Dr. Reddy’s Laboratories and Zydus Lifesciences. These names help position Laurus Labs Share Price against comparable listed pharma companies. Comparable listed companies include Cipla Ltd., Aurobindo Pharma Ltd., Lupin Ltd.

Where can I track Laurus Labs Share Price on Univest?

Ans. Univest allows users to track Laurus Labs Share Price, shareholding pattern, fundamental ratios, market insights and 52-week levels in one place. That makes it useful for ongoing Laurus Labs Stock News tracking.